(Reuters) - The FDA raised eight matters of concern at the time and
found four areas of noncompliance following Staar's initial
response to the FDA. Staar said it expects to provide its
written response to the FDA on or before the July 18 deadline
cited in the warning letter.
Read more at Reuters.com Government Filings News
found four areas of noncompliance following Staar's initial
response to the FDA. Staar said it expects to provide its
written response to the FDA on or before the July 18 deadline
cited in the warning letter.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment